Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vaccine strategies against Epstein-Barr virus-associated diseases: lessons from studies on cytotoxic T-cell-mediated immune regulation.

Immunological reviews - 1 Aug 1999

Khanna R, Moss D J, Burrows S R

Abstract excerpt

Development of a vaccine against Epstein-Barr virus (EBV) is constrained by the latency phenotypes adopted by different EBV-associated diseases. Over the last few years an immense body of information on the pattern of viral gene expression in EBV-associated diseases and the role of cytotoxic T cells in the control of these diseases has accumulated. It would seem reasonable to suggest that emerging technologies...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Viral
Share to Burkitt Lymphoma
Share to Epstein-Barr Virus Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Herpesvirus 4, Human

Share to Immunotherapy

Share to Primates

Share to T-Lymphocytes, Cytotoxic

Share to Viral Vaccines

Source

Identifiers

PMID: 10566141
DOI: 10.1111/j.1600-065x.1999.tb01328.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vaccine strategies against Epstein-Barr virus-associated diseases: lessons from studies on cytotoxic T-cell-mediated immune regulation.PMID 10566141Read ↗

Immunotherapeutic strategies for EBV-associated malignancies.Semantic proximity Read ↗

Immune regulation in Epstein-Barr virus-associated diseasesSemantic proximity Read ↗

The human T cell immune response to Epstein-Barr virusSemantic proximity Read ↗

Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target AntigensSemantic proximity Read ↗

T cell-mediated immunity during Epstein–Barr virus infections in childrenSemantic proximity Read ↗

MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In VivoSemantic proximity Read ↗

Role of Cytotoxic T Lymphocytes in Epstein-Barr Virus-Associated DiseasesSemantic proximity Read ↗

The immunology of Epstein-Barr virus infection.Semantic proximity Read ↗

Epstein–Barr virus infection: basis of malignancy and potential for therapySemantic proximity Read ↗

HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTIONSemantic proximity Read ↗

Epstein–Barr virus microRNAs reduce immune surveillance by virus-specific CD8 + T cellsSemantic proximity Read ↗

Redirecting T Cells against Epstein–Barr Virus Infection and Associated OncogenesisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.